Used as a protected nucleoside intermediate in the synthesis of antiviral and anticancer agents, particularly in the preparation of modified RNA or DNA analogs. The silyl protecting groups allow selective manipulation of hydroxyl functionalities during oligonucleotide assembly, making it valuable in pharmaceutical research and development of nucleoside-based therapeutics. Commonly employed in solid-phase synthesis and used to enhance stability and solubility during multi-step reactions.